Oligodendrocytes: Structure and Function | Neurobiology

Multiple sclerosis (MS) is a demyelinating disease characterized by damage to the insulating myelin sheaths surrounding nerve cells in the brain and spinal cord. This damage impairs communication within parts of the nervous system, leading to a variety of physical, mental, and sometimes psychiatric symptoms. Common manifestations include double vision, blindness in one eye, muscle weakness, impaired sensation, and coordination difficulties. MS presents in multiple forms: relapsing forms involve new symptoms occurring in isolated attacks, while progressive forms involve gradual symptom accumulation. Between attacks, symptoms may fully resolve, but permanent neurological deficits often persist, particularly as the disease advances. The exact cause remains unclear, but the underlying mechanism is believed to involve immune-mediated destruction of myelin or failure of myelin-producing cells. Proposed contributing factors include genetic predisposition and environmental triggers such as viral infections. Diagnosis is based on clinical signs, symptoms, and supporting medical tests. There is no known cure for MS. Treatments aim to restore function after an attack and prevent new episodes. Medications used are only modestly effective and may cause side effects or poor tolerance. Physical therapy is recommended to support functional ability. Many patients seek alternative treatments despite insufficient evidence. Prognosis varies; better outcomes are typically associated with female sex, early disease onset, a relapsing course, and low initial attack frequency. Life expectancy is, on average, 5 to 10 years lower than in the general population.

Multiple Sclerosis (MS) is a chronic, immune-mediated demyelinating disease of the central nervous system characterized by an autoimmune response where autoreactive T-cells and inflammatory cytokines attack myelin sheaths surrounding axons, leading to disrupted neural signal transmission; the disease primarily affects young adults (ages 20-40), with environmental factors like low vitamin D levels and viral infections (Epstein-Barr virus, HHV-6) combined with genetic susceptibility genes such as HLA-DR2 contributing to its development; clinically, MS presents with diverse neurological deficits including optic neuritis, bilateral internuclear ophthalmoplegia, pseudobulbar palsy, and spinal cord involvement, manifesting through four main subtypes: relapsing-remitting (90% of cases with flare-ups and partial recovery), secondary progressive (progressive deterioration after initial relapsing phase), primary progressive (continuous decline without relapses), and progressive-relapsing (continuous deterioration with non-recovering flare-ups); diagnosis relies on MRI showing characteristic white matter lesions in peri-ventricular regions, brainstem, and spinal cord, supported by visual evoked potentials and lumbar puncture findings; treatment includes acute management with high-dose corticosteroids and plasmapheresis, plus disease-modifying therapies such as interferon beta, glatiramer acetate, monoclonal antibodies, and natalizumab to suppress immune activity and prevent future relapses.

Multiple sclerosis is an autoimmune disorder where oligodendrocytes (myelinating cells of the CNS) are destroyed, leading to demyelination of CNS neurons. This disrupts nerve conduction and causes the various neurological symptoms of MS. The destruction of oligodendrocytes is the primary pathological feature.

Multiple sclerosis is a leading central nervous system disease affecting brain and spinal cord. Myelin, the protective sheath around axons, enables faster nerve impulse transmission. MS involves demyelination where immune cells attack and destroy myelin, disrupting neural communication. The blood-brain barrier normally protects neurons, but activated B-lymphocytes target barrier cells, allowing T-cells to breach it. This triggers Type IV hypersensitivity where T-cells produce cytokines (IL-1, IL-6, TNF, IFN-gamma) that expand vascular walls, recruit B-lymphocytes and macrophages, and destroy myelin. Attacks occur in waves with initial remyelination, but over time damage becomes irreversible. Risk factors include female gender, HLA-DR2 gene, infections, and vitamin D deficiency, explaining higher prevalence in polar regions.

MS pathophysiology involves a complex cascade: foreign antigens (possibly viral) sensitize T lymphocytes, which breach the blood-brain barrier by disrupting endothelial membranes. Activated lymphocytes enter the CNS and bind to CD4 cells, triggering B lymphocytes to produce antibodies. The disease has both inflammatory and degenerative components, with the inflammatory phase (Big Bang) followed by neurodegeneration. Etiological factors include Epstein-Barr virus infection (10x more frequent in MS patients), vitamin D deficiency, and smoking (causing nitric oxide toxicity, altered immunity, and increased blood-brain barrier permeability). Genetic factors include major histocompatibility complex genes. The interplay between genetic predisposition and environmental triggers remains incompletely understood.

Myelin sheaths are multi-layered lipid-protein coverings that insulate axons and increase nerve impulse conduction speed. In the CNS, oligodendrocytes produce myelin around multiple axons; in the PNS, Schwann cells produce myelin around single axons. The neurolemma (Schwann cell outer layer) enables PNS regeneration but is absent in CNS myelination. Nodes of Ranvier are gaps between myelinated segments. Key CNS vs PNS differences include: terminology (ganglion vs nucleus, nerve vs tract); white matter (myelinated axons) vs gray matter (cell bodies); spinal cord (gray matter core) vs brain (gray matter outer layer); and regeneration capacity (PNS regenerates, CNS has limited regeneration).

Oligodendrocytes and Schwann cells differ fundamentally in their myelination capabilities. Oligodendrocytes can myelinate multiple axons simultaneously using multiple processes, while Schwann cells myelinate only one axon each, requiring multiple cells per axon. Axon diameter determines myelination status, with only axons above approximately 1 micrometer diameter receiving myelin sheaths. Dendrites and small-diameter axons like mossy fibers remain unmyelinated. In the PNS, some axons form Remak bundles wrapped by single non-myelinating Schwann cells, a phenomenon absent in the CNS.

The PNS contains Schwann cells that form myelin sheaths and enable nerve regeneration after injury, unlike CNS oligodendrocytes. Satellite cells protect neuronal cell bodies by enveloping them. The fundamental difference between CNS and PNS repair capacity lies in whether myelination uses oligodendrocytes (non-regenerative) or Schwann cells (regenerative), explaining why peripheral nerve injuries typically heal better than central nervous system injuries.

The nervous system consists of the central nervous system (CNS) and peripheral nervous system (PNS). In the PNS, Schwann cells produce myelin sheaths, with each Schwann cell covering only one segment of an axon. In the CNS, oligodendrocytes produce myelin sheaths, with each oligodendrocyte capable of myelinating multiple axons. Nerve regeneration occurs primarily in the PNS because Schwann cells contain neurolemma, the site of regeneration. Each Schwann cell covers only one axon segment, allowing for regeneration. In contrast, oligodendrocytes in the CNS can myelinate multiple axons simultaneously, which limits regeneration capability.

Oligodendrocytes are the most numerous glial cells in the CNS, originating from neural stem cells. They exist in both gray and white matter and support myelination of axons. Each oligodendrocyte myelinates multiple segments of axons within a single ganglion. Schwann cells (myelinating cells in the PNS) are flat cells that myelinate single segments of nerve fibers. Both are myelinating cells but differ in structure and location. Schwann cells are important for nerve regeneration, while oligodendrocytes do not participate in regeneration.

Evidence supports that myelination is activity-dependent rather than hardwired. Transcriptomic comparisons between four-month-olds with visual experience and prenatal samples show increased myelination gene expression. Animal studies demonstrate that depriving monkeys of visual input prevents face-selective response emergence. This suggests visual experience accelerates myelination in higher-order visual areas, creating an interplay between structural changes and functional developments in infant brain maturation.

The brain's white matter, comprising approximately half the brain volume, consists of oligodendrocytes wrapping myelin sheaths around axons. This architecture maximizes neural connectivity with minimal conduction delays, providing maximum computational power. Myelin sheaths lower axonal capacitance and increase resistance, enabling faster action potential propagation. Recent evidence reveals myelination is not uniform along axons—alternating unmyelinated and myelinated segments allow differential speed adjustments, enabling synchronized firing across neurons of different lengths. Myelination begins late in human development, starting in anterior brain regions shortly after birth and continuing through childhood and adolescence. Oligodendrocyte precursor cells (OPCs) are born during early development when neurons have already projected to their targets and become active. OPCs migrate throughout the brain, proliferate, and differentiate into myelinating oligodendrocytes. These OPCs possess voltage-gated sodium channels and receive synaptic inputs from glutamatergic neurons, expressing NMDA, AMPA, and kainate receptors, establishing direct neural-oligodendrocyte communication pathways. Myelination is regulated by two distinct mechanisms: activity-independent myelination occurring autonomously, and activity-dependent myelination requiring neural activity and glutamate receptor signaling. OPCs exhibit significant heterogeneity in their properties across different brain regions and developmental stages, transitioning through naive, primed, and quiescent states. Myelin plasticity supports learning and skill acquisition—professional pianists show corpus callosum thickness correlating linearly with practice hours, and mouse studies demonstrate that motor skill learning requires new myelinating oligodendrocytes.

This section covers oligodendrocyte precursor cells and myelination processes. OPCs establish axon-glial synapses and differentiate into myelinating oligodendrocytes in response to neuronal activity. Enriched environments automatically increase OPC proliferation and myelination throughout the hippocampus, cortex, and white matter. Activity-dependent myelination explains why learning thickens myelin while inactivity thins it. Stimulation at 25 Hz and 300 Hz promotes greater myelination than 5 Hz stimulation. The corpus callosum transmits signals in 30 ms (myelinated) versus 333 ms (unmyelinated), demonstrating how myelination speed affects neural communication. Myelinated nerves support faster conduction velocities and better phase coherence between brain regions.

Human infants undergo extraordinary neurodevelopment in their first year, producing approximately 500 billion synapses daily, 14,000 new hippocampal neurons per day, and 127 million cerebellar granule neurons per day. Myelin development is primarily postnatal, beginning just before birth with minimal myelin in central brain regions, progressing from the brain's center toward the poles over the first year and continuing for approximately three decades. Myelination follows predictable topographical and chronological patterns, with basic neural circuits underlying sensation and movement myelinating first, followed by higher-order circuits supporting cognition during adolescence and young adulthood. The spatial and temporal pattern of glioma genesis maps onto the pattern of developmental myelination, suggesting that the cell of origin for many gliomas lies in the oligodendroglial lineage. Research demonstrates that neuronal activity in cortical projection neurons elicits rapid and robust proliferation of oligodendrocyte precursors, generating mature oligodendrocytes that alter circuit dynamics and improve behavioral outcomes. Molecular mechanisms involve brain-derived neurotrophic factor (BDNF) signaling through TrkB receptor, which is required for activity-dependent OPC proliferation. Activity-dependent myelin plasticity manifests in two forms: generation of new oligodendrocytes forming new myelin internodes on previously unmyelinated axons, and remodeling of existing myelin by mature oligodendrocytes changing internode geometry. Healthy activity-dependent myelination promotes coordinated circuit functions by synchronizing inputs between neural network nodes, enhancing attention, memory, and learning. However, in cognitive impairment syndromes such as cancer therapy-related brain fog and post-COVID cognitive dysfunction, myelin homeostasis and plasticity become impaired due to neural-immune interactions. In generalized epilepsy syndromes, aberrantly increased neuronal activity leads to aberrantly increased myelination within the seizure network, contributing to epilepsy progression by promoting hypersynchrony between nodes.

Myelination spans over 30 years in humans, beginning postnatally and continuing throughout life. The concept that neuronal activity regulates axon myelination emerged in the 1990s, proposing neurons control myelination extent through experience-dependent mechanisms. Using in vivo optogenetics, researchers demonstrated that stimulating cortical projection neurons rapidly increases oligodendrocyte precursor cell proliferation, generating new oligodendrocytes that alter myelin ultrastructure and improve motor function. A key molecular mechanism involves BDNF-TrkB signaling: genetic models with impaired BDNF secretion or TrkB receptor deletion from oligodendrocyte precursor cells completely lose activity-regulated myelination responses. Loss of this myelination impairs attention and short-term memory function, demonstrating myelin plasticity supports cognition by promoting network synchrony through coordinated neural circuit function.